BiomX
Executivos
Veja o organograma con seus 12 executivos principais
Biografias mais buscadas da BiomX
- Jonathan Solomon, Chief Executive Officer and Board Member
- Jason Marks, Director
- Lynne Sullivan, Director
Recentes movimentos de executivos em BiomX
- Susan Blum, ingressou na Companhia como Director (Notícia publicada em 19 de abril de 2024).
Criar um alerta
para seguir os movimentos de executivos da BiomX.
Biotecnologia
BiomX possui 2.289 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Attovia Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 14 de maio de 2024).
- Bruker has announced the acquisition of NanoString Technologies (publicado em 13 de maio de 2024).
- Aardvark Therapeutics acaba de anunciar uma arrecadação de fundos de 85 milhões de dólares. (publicado em 12 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de BiomX
- BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
- BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- BiomX Announces the Appointment of Susan Blum to its Board of Directors
- BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
- BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Press Releases
- BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
- BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
- BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
- BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fibrosis
- View more press releases Close
Redes sociais sobre BiomX
- BiomX na Wikipedia, Google News e Yahoo Finance
- BiomX na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Jonathan Solomon 
Ligue para a BiomX em +972 ...
